.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Fish and Richardson
Cipla
Johnson and Johnson
Harvard Business School
Mallinckrodt
Cantor Fitzgerald
Argus Health
McKinsey

Generated: January 16, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: nintedanib esylate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Boehringer IngelheimOFEVnintedanib esylateCAPSULE;ORAL205832NDABoehringer Ingelheim Pharmaceuticals, Inc.0597-0143-601 BOTTLE in 1 CARTON (0597-0143-60) > 60 CAPSULE in 1 BOTTLE
Boehringer IngelheimOFEVnintedanib esylateCAPSULE;ORAL205832NDABoehringer Ingelheim Pharmaceuticals, Inc.0597-0145-601 BOTTLE in 1 CARTON (0597-0145-60) > 60 CAPSULE in 1 BOTTLE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Daiichi Sankyo
Queensland Health
Baxter
US Department of Justice
Deloitte
Healthtrust
McKinsey
UBS
Covington

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot